Back
ESC Premium Access

The ablation of VEGFR-1 signaling promotes angiotensin II induced cardiac dysfunction and sudden death

Session: Poster Session 2 - Cardiac hypertrophy
Topic: Cardiac Hypertrophy
Speaker: Doctor A. Tirronen (Kuopio, FI)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Annakaisa Tirronen

University of Eastern Finland, Kuopio (Finland)
0 follower

11 more presentations in this session

Glutamine-fructose-6-phosphate amidotransferase 2 mediates isoproterenol-induced cardiac hypertrophy by increasing Akt O-GlcNAcylation through hexosamine biosynthesis pathway

Speaker: Doctor A. Ishikita (Fukuoka, JP)

Access
Abstract
Like
Thumbnail

Epigenetic modifications via histone acetylation by p300 are changed during the transition from cardiac hypertrophy to heart failure

Speaker: Mr Y. Sunagawa (Shizuoka, JP)

Access
Abstract
Like
Thumbnail

Inhibition of GATA4 dimerization suppress hypertrophic responses

Speaker: Mr S. Shimizu (Shizuoka, JP)

Access
Abstract
Like
Thumbnail

Adverse left ventricular remodeling in descending thoracic vs ascending aorta banding in novel porcin model. cMRI study

Speaker: Doctor S. Popevska (Leuven, BE)

Access
Abstract
Slides
Like
Thumbnail

The genetic background of the disease in a group of patients with severe course of hypertrophic cardiomyopathy.

Speaker: Doctor M. Klopotowski (Warsaw, PL)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Cardiac hypertrophy

Speakers: Doctor A. Tirronen, Doctor A. Ishikita, Mr Y. Sunagawa, Mr S. Shimizu, Doctor S. Popevska...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources